Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns

Submitted by admin on October 30, 2019 - 10:32am

Source:

Stat

News Tags:

Novartis

Zolgensma

FDA

gene therapy

clinical trials

SMA

Headline:

Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns

snippet:

The Food and Drug Administration has halted a clinical trial of Novartis’ Zolgensma gene therapy due to a safety concern found in an animal study, the company said Wednesday.

Search form

You are here

Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns

Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns